| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |